Choate Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
2,175
-271
-11% -$152K 0.02% 234
2026
Q1
$1.37M Buy
2,446
+34
+1% +$21.8K 0.03% 199
2025
Q4
$1.63M Buy
2,412
+31
+1% +$21.1K 0.03% 180
2025
Q3
$1.52M Buy
2,381
+4
+0.2% +$2.43K 0.03% 174
2025
Q2
$1.27M Sell
2,377
-2
-0.1% -$956 0.03% 177
2025
Q1
$999K Buy
2,379
+288
+14% +$125K 0.02% 189
2024
Q4
$865K Buy
2,091
+39
+2% +$17.1K 0.02% 208
2024
Q3
$1.04M Buy
2,052
+8
+0.4% +$3.89K 0.03% 194
2024
Q2
$996K Buy
2,044
+2
+0.1% +$1K 0.03% 191
2024
Q1
$1.1M Buy
2,042
+82
+4% +$44.8K 0.03% 190
2023
Q4
$1.09M Sell
1,960
-39
-2% -$18.3K 0.03% 172
2023
Q3
$874K Buy
+1,999
New +$997K 0.03% 178
2016
Q1
Sell
-4,320
Closed -$641K 265
2015
Q4
$641K Sell
4,320
-4,594
-52% -$328K 0.05% 146
2015
Q3
$662K Hold
8,914
0.05% 132
2015
Q2
$572K Hold
8,914
0.03% 151
2015
Q1
$689K Buy
8,914
+274
+3% +$21.3K 0.04% 145
2014
Q4
$641K Hold
8,640
0.04% 147
2014
Q3
$509K Hold
8,640
0.03% 172
2014
Q2
$577K Hold
8,640
0.03% 164
2014
Q1
$524K Hold
8,640
0.03% 173
2013
Q4
$460K Hold
8,640
0.03% 185
2013
Q3
$430K Sell
8,640
-4,160
-33% -$200K 0.03% 177
2013
Q2
$574K Buy
+12,800
New +$559K 0.05% 153

Other funds holding IDXX

Choate Investment Advisors's IDXX Position: Q2 2026 in Review

Choate Investment Advisors reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $152K and leaving 2,175 shares worth $1.15M. The position accounts for 0.02% of the portfolio, ranked #234.

Choate Investment Advisors first reported a position in IDXX in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.63M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Choate Investment Advisors held 2,175 shares of Idexx Laboratories worth $1.15M as of Q2 2026.
  • Choate Investment Advisors sold 271 Idexx Laboratories shares in Q2 2026, an estimated $152K.
  • Idexx Laboratories made up 0.02% of Choate Investment Advisors's portfolio in Q2 2026, its #234 holding.
  • Choate Investment Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 23 quarters since.
  • Choate Investment Advisors's Idexx Laboratories position peaked at $1.63M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.